inSoma Bio, Inc. filed an amended Form D with the Securities and Exchange Commission on 2025-10-20.
inSoma Bio, Inc. filed an amended Form D notice of an exempt securities offering with the SEC on October 20, 2025. The filing reports $2.69M sold. Its industry group is Biotechnology. It names Stefan Roberts (Executive Officer, Director), Ashutosh Chilkoti (Executive Officer, Director), Juliana Blum (Director) (SEC Form D/A, October 20, 2025).
Is this your company?
Sell to companies like inSoma Bio, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-10-20 · the record
Pitching, partnering or investing alongside them? See who really runs and owns inSoma Bio, Inc.
Free to see. No signup.
More on the people and the money behind inSoma Bio, Inc., from the filings we hold.
Biotechnology raises by companies based in North Carolina, filed within 90 days of this one, largest first.
Get an email when inSoma Bio, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when inSoma Bio, Inc. raises, hires or launches. No email unless you switch it on.
Watch inSoma Bio, Inc. →Get the full cited report on inSoma Bio, Inc.
What the filing shows about inSoma Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on inSoma Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives inSoma Bio, Inc.'s address as 701 W. Main Street, Suite 410, Durham, NC 27701.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for inSoma Bio, Inc. →
Amended on 2026-01-22: the offering size changed from $3,000,000 to $4,000,000; the amount sold changed from $1,925,572 to $2,689,372; the number of investors changed from 8 to 15. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
inSoma Bio, Inc. is a registered filer with the SEC (CIK 1814250) and has filed since 2023-05-01. 5 filings are on record, the latest on 2026-01-22.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
inSoma Bio, Inc.'s Form D of 2025-10-20 names Stefan Roberts, Ashutosh Chilkoti, Juliana Blum and 2 more as its officers, directors or promoters.
Its new offerings report $3.03M sold across 2 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Other than the payment of salaries and other compensation and benefits and reimbursement of expenses, no officer, director, partner, manager or promoter will receive any payments from the proceeds of this offering.
Checked away from the filing. What is below does not come from the record on sec.gov.
At inSoma Bio we borrow nature’s own designs to develop unique products for reconstructive plastic surgery.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Stefan Roberts is named as Executive Officer and Director on the Form D that inSoma Bio, Inc. filed with the SEC on 20 October 2025, one of 5 people that filing names.
Ashutosh Chilkoti is named as Executive Officer and Director on the Form D that inSoma Bio, Inc. filed with the SEC on 20 October 2025, one of 5 people that filing names.
Juliana Blum is named as Director on the Form D that inSoma Bio, Inc. filed with the SEC on 20 October 2025, one of 5 people that filing names.
Heather Brennan is named as Director on the Form D that inSoma Bio, Inc. filed with the SEC on 20 October 2025, one of 5 people that filing names.
June Almenoff is named as Director on the Form D that inSoma Bio, Inc. filed with the SEC on 20 October 2025, one of 5 people that filing names.
5 people named on the filing — 2 holding an executive role and 3 as directors only.
Named as of the 2025-10-20 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about inSoma Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on inSoma Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on inSoma Bio, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist inSoma Bio, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind inSoma Bio, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-10-30 (insomabio.com).
Each opens in a new tab, filled in for inSoma Bio, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Raleigh-Durham
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/insoma-bio-inc-form-d-25000001